A new AI-driven diagnostic tool for COPD, N-Tidal Diagnose, is set to launch across the NHS from April 14, marking a significant advancement in respiratory care.
Key Highlights:
- First non-spirometry-based AI test for COPD approved under EU Medical Device Regulations.
- Delivers an accurate diagnosis in under 5 minutes via normal breathing.
- Reduces pressure on GPs by enabling use in community settings by healthcare assistants.
- Set to improve early detection for up to 2 million undiagnosed patients in the UK.
Developed by TidalSense, the device analyzes CO₂ waveforms using AI—offering a faster, easier alternative to spirometry, which dates back to the 1800s and often causes diagnostic delays.
With COPD costing the NHS £1.9B annually, this innovation could save £15.9M per year in misdiagnosis-related costs while cutting long wait times and improving patient outcomes across the UK.
Follow MEDWIRE.AI for the latest in AI healthtech innovation.
